MetaADEDB 2.0 @ LMMD
Ganfort
(ISZJXIYRLAGBMH-IQMDKZJJSA-N)
Structure
SMILES
O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C.CCNC(=O)CCC/C=C\CC1C(O)CC([C@@H]1/C=C/C(CCc1ccccc1)O)O
Molecular Formula:
C38H61N5O7S
Molecular Weight:
731.985
Log P:
4.4962
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
6
TPSA:
197.77
CAS Number(s):
946163-60-6
Synonym(s)
1.
Ganfort
External Link(s)
MeSHC571755
PubChem Compound126480208
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AmnesiaFAERS: 7US FAERS
2Eye painFAERS: 6US FAERS
3VertigoFAERS: 6US FAERS
4DizzinessFAERS: 5US FAERS
5Eye irritationFAERS: 5US FAERS
6HeadacheFAERS: 5US FAERS
7Atrial FibrillationFAERS: 4US FAERS
8AsthmaFAERS: 3US FAERS
9CataractFAERS: 3US FAERS
10DiplopiaFAERS: 3US FAERS
11UveitisFAERS: 3US FAERS
12AphasiaFAERS: 2US FAERS
13BlindnessFAERS: 2US FAERS
14BradycardiaFAERS: 2US FAERS
15Choroidal DetachmentFAERS: 2US FAERS
16FatigueFAERS: 2US FAERS
17Feeling abnormalFAERS: 2US FAERS
18GlaucomaFAERS: 2US FAERS
19IridocyclitisFAERS: 2US FAERS
20LymphomaFAERS: 2US FAERS
21Ocular HypertensionFAERS: 2US FAERS
22Ocular discomfortFAERS: 2US FAERS
23Skin necrosisFAERS: 2US FAERS
24StomatitisFAERS: 2US FAERS
25Altered state of consciousnessFAERS: 1US FAERS
26Amnestic DisorderFAERS: 1US FAERS
27AstheniaFAERS: 1US FAERS
28Atrioventricular BlockFAERS: 1US FAERS
29BronchospasmFAERS: 1US FAERS
30Burning sensationFAERS: 1US FAERS
31Cerebrovascular accidentFAERS: 1US FAERS
32Chest PainFAERS: 1US FAERS
33ConjunctivitisFAERS: 1US FAERS
34Corneal dystrophyFAERS: 1US FAERS
35DementiaFAERS: 1US FAERS
36DiscomfortFAERS: 1US FAERS
37DissociationFAERS: 1US FAERS
38EpistaxisFAERS: 1US FAERS
39ExophthalmosFAERS: 1US FAERS
40Eye allergyFAERS: 1US FAERS
41Eyelid dermatochalasisFAERS: 1US FAERS
42Eyelids pruritusFAERS: 1US FAERS
43Foreign body sensation in eyesFAERS: 1US FAERS
44Growth of eyelashesFAERS: 1US FAERS
45Head discomfortFAERS: 1US FAERS
46HepatitisFAERS: 1US FAERS
47HypersensitivityFAERS: 1US FAERS
48Incorrect dose administeredFAERS: 1US FAERS
49InfectionFAERS: 1US FAERS
50Intentional product misuseFAERS: 1US FAERS
51Intraocular pressure test abnormalFAERS: 1US FAERS
52Iris hyperpigmentationFAERS: 1US FAERS
53Lid sulcus deepenedFAERS: 1US FAERS
54Macular degenerationFAERS: 1US FAERS
55Memory impairmentFAERS: 1US FAERS
56MyalgiaFAERS: 1US FAERS
57Optic AtrophyFAERS: 1US FAERS
58Periorbital fat atrophyFAERS: 1US FAERS
59Peripheral swellingFAERS: 1US FAERS
60PresbyopiaFAERS: 1US FAERS
61Pulmonary EmbolismFAERS: 1US FAERS
62Retinal DetachmentFAERS: 1US FAERS
63Retinal scarFAERS: 1US FAERS
64RhinitisFAERS: 1US FAERS
65SchizophreniaFAERS: 1US FAERS
66SomnolenceFAERS: 1US FAERS
67Symptom maskedFAERS: 1US FAERS
68ThrombocytopeniaFAERS: 1US FAERS
69TinnitusFAERS: 1US FAERS
70TrabeculectomyFAERS: 1US FAERS
71Visual ImpairmentFAERS: 1US FAERS
72Vitreous opacitiesFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.